Pharmafile Logo
Pharmafocus logo
Advanced Search

emerging markets

Showing 15 posts of 52 posts found.

Huge increase in emerging market spending to lift pharma

July 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging

The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …

Feature

Eisai to enter Russia with epilepsy launch

June 27, 2012
Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy

Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …

News

Access to new cancer drugs limited in Brazil and Mexico

April 13, 2012
Sales and Marketing Brazil, Cancer, Mexico, avastin, emerging markets

Between one-quarter and one-third of patients in Brazil and Mexico who are eligible for treatment with new cancer drugs do …

News
Steve Yang

Innovating in China’s pharma market

April 12, 2012
Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets

The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …

Feature

India’s Nexavar patent ruling disturbs pharma

March 12, 2012
Sales and Marketing India, emerging markets, intellectual property, patents

India is to allow Bayer’s cancer treatment Nexavar to be subject to a compulsory licence, allowing a generic firm to …

News
Merck image

Merck unveils Brazilian joint venture

February 17, 2012
Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets

Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …

News

Quintiles launches new Asian market service

February 13, 2012
Research and Development Asia, Quintiles, emerging markets

Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …

News
Lucentis image

Lucentis approved in China

January 18, 2012
Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets

Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …

News
Merkel and Sarkozy

2011 Year In Review

January 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review

A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …

Feature

GSK faces fine over Argentina clinical trial

January 6, 2012
Research and Development, Sales and Marketing Argentina, GSK, Vaccine, deaths, emerging markets

A court in Argentina says GSK should be fined for irregularities in recruitment during a trial in which children died. …

News

BMS in cholesterol alliance with China’s Simcere

December 16, 2011
Sales and Marketing BMS, CETP inhibitor, Simcere, cardiovascular, emerging markets

Bristol-Myers Squibb is to co-develop a new compound to treat cardiovascular disease with Chinese firm Simcere Pharmaceutical Group. The companies, …

News

Bayer forecasts €11 billion growth in Asia

November 17, 2011
Bayer, China, emerging markets

Bayer is expecting sales in Asia to grow by €11 billion over the next four years, with over half of …

News

Emerging markets help Bayer through tough quarter

October 28, 2011
Sales and Marketing Bayer, Xarelto, emerging markets

Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …

News
Lundbeck headquarters, Denmark

Lundbeck establishes research centre in China

October 18, 2011
Research and Development Brain disorders, CNS, China, Lundbeck, Shanghai, emerging markets

Lundbeck has set up a new research centre in China, joining a wave of pharma companies investing in the region. The …

News

Actavis plans ‘major’ sales expansion in Latin America

October 6, 2011
Sales and Marketing Actavis, emerging markets, generics

Swiss company Actavis has launched a new business unit to target the fast-growing Latin American generics market. Mirroring the branded …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025